You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | 0.0% | n/a |
ROCE | 0.0% |
Latest | Forecast | |
---|---|---|
P/E | -4.0 | 0.0 |
PEG | 0.0 | -999,999.0 |
Price / Revenue | 0.0 | 0.0 |
Price / Book value | 2.8 |
Latest | Forecast | |
---|---|---|
Revenue | n/a | 0.0% |
PBT | 0.0% | n/a |
EPS | 0.0% | 0.0% |
DPS | n/a | 0.0% |
Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2018-12-31 | n/a | -4.83 | -117.50p | -0.9 | 0.0 | n/a | n/a | 0.0% |
2019-12-31 | n/a | -2.72 | -4,135.00p | 0.0 | 0.0 | n/a | n/a | 0.0% |
2020-12-31 | n/a | -1.54 | -3.81p | -5.1 | 0.0 | n/a | n/a | 0.0% |
2021-12-31 | n/a | -1.68 | -2.34p | -15.5 | 0.0 | n/a | n/a | 0.0% |
ValiRx incorporates new wholly-owned lab subsidiary Sharecast News | 01 Mar |
---|---|
ValiRx forms new majority-owned breast cancer subsidiary Sharecast News | 24 Oct |
ValiRx expecting to grant extension of exclusivity to TheoremRx Sharecast News | 17 Jun |
Notice of Results and Investor Webinar | 26-May-23 14:24 |
---|---|
Collaborative Services Agreement | 26-Apr-23 15:31 |
Quarterly Operational Update | 31-Mar-23 14:58 |